Webinar: Urolithiasis: Metabolic Evaluation & Medical Treatment (2020)

August 18, 2020

Course Director: Michael E. Lipkin, MD

The course is centered on reviewing medical management and prevention of kidney stones. A focus is on the AUA guidelines for the medical management of stones. The course is focused on practical information, for example, how to interpret 24 hour urines, when to prescribe medication. It also has a focus on dietary management for stones.

Please note this course is FREE to all AUA Members and is an exclusive member benefit.  If you would like to become an AUA Member, we'd be happy to have you - think about all the great member benefits!

Target Audience

  • Urologists
  • Residents
  • Advanced Practice Providers (Nurse Practitioners and Physician Assistants)

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Interpret a 24 hour urine collection and identify underlying metabolic causes for recurrent stone disease.
  2. Prescribe appropriate medical treatment for the prevention of kidney stones based on findings on a 24 hour urine collection.
  3. Prescribe targeted dietary changes for underlying metabolic abnormalities on 24 hour urine testing such as hypercalciuria, hyperoxaluria, and hypocitraturia.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
06/29/2020
Course expires: 
08/18/2023
Event starts: 
08/18/2020 - 7:00pm EDT
Event ends: 
08/18/2020 - 8:30pm EDT
Part of: 
Summer School Webinar Series (2020)
Add to calendar: 
Rating: 
0

Scientific Agenda

Urolithiasis: Metabolic Evaluation & Medical Treatment

7:00 pm               Welcome, Housekeeping Notes

AUA

7:03 pm               Indications for and Interpretation of Metabolic Stone Evaluation

Jodi Antonelli, MD

UT Southwestern Medical Center

7:20 pm               Using Thiazides to Treat Stone Disease

Sara L. Best, MD

University of Wisconsin School of Medicine and Public Health

7:40 pm               When To Give Potassium Citrate

Michael Lipkin, M.D., M.B.A.

Duke University Medical Center

8:00 pm               Dietary prevention of stone disease and dietary treatment of hyperoxaluria

Brian Eisner, MD

Massachusetts General Hospital, Harvard Medical School

8:20 pm               Q&A

All Faculty

8:30 pm               WEBINAR ADJOURNS – BROADCAST ENDS 

Urolithiasis: Metabolic Evaluation & Medical Treatment (2020) will be held virtually on Tuesday, August 18 at 7 PM EST.

***Instructions***

  1. Click the "Register" tab.
  2. If prompted, click “update your profile”. Otherwise, click “Take Course”.
  3. Click “Start” under Live Webinar in the Course Progress pane.
  4. Click "Join Webinar".

Education Council Disclosures

PDF icon Ed Council & COI Reviewer Disclosures_081820.pdf

AUA Office of Education Staff has nothing to disclose.

 

 

 

Course Director(s)

Michael Lipkin, MD

has a financial relationship (Other) with Lumenis;.
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with Boston Scientific;.
Faculty(s)

Jodi Antonelli, MD

has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with Boston Scientific;.

Sara Best, MD

has a financial relationship (Other) with Richard Wolf;.
has a financial relationship (Other) with American Urological Association;.
has a financial relationship (Other) with American Urological Association;.
has a financial relationship (Other) with Richard Wolf;.
has a financial relationship (Other) with Richard Wolf;.
has a financial relationship (Other) with American Urological Association;.

Brian Eisner, MD

has a financial relationship (Stock) with Kalera Medical;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with Sonomotion;.
has a financial relationship (Independent contractor) with Sonomotion;.
has a financial relationship (Independent contractor) with Allena Pharmaceuticals;.
has a financial relationship (Independent contractor) with Allena Pharmaceuticals;.
has a financial relationship (Stock) with Dr. Arnies LLC;.
has a financial relationship (Stock) with Dr. Arnies LLC;.
has a financial relationship (Stock) with Kalera Medical;.
has a financial relationship (Independent contractor) with Boston Scientific;.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.

To join the webinar:

  1. Click on the TAKE COURSE button.
  2. Click “Start” under Live Webinar in the Course Progress pane.
  3. Click "Join Webinar".